SILO
Price:
$1.03
Market Cap:
$4.62M
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal comp...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
NASDAQ
Ticker
SILO
According to Silo Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 112.69K. This represents a change of -93.49% compared to the average of 1.73M of the last 4 quarters.
The mean historical Enterprise Value of Silo Pharma, Inc. over the last ten years is 11.42M. The current 112.69K Enterprise Value has changed -1.31% with respect to the historical average. Over the past ten years (40 quarters), SILO's Enterprise Value was at its highest in in the September 2020 quarter at 27.92M. The Enterprise Value was at its lowest in in the June 2024 quarter at -1502476.66.
Average
11.42M
Median
15.95M
Minimum
-3691987.60
Maximum
21.97M
Discovering the peaks and valleys of Silo Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 169.16%
Maximum Annual Enterprise Value = 21.97M
Minimum Annual Increase = -199.01%
Minimum Annual Enterprise Value = -3691987.60
Year | Enterprise Value | Change |
---|---|---|
2023 | 910.71K | -124.67% |
2022 | -3691987.60 | -199.01% |
2021 | 3.73M | -83.03% |
2020 | 21.97M | 169.16% |
2019 | 8.16M | -51.61% |
2018 | 16.87M | -2.11% |
2017 | 17.23M | 1.44% |
2016 | 16.99M | 0.05% |
2015 | 16.98M | 12.98% |
2014 | 15.03M | 60.63% |
The current Enterprise Value of Silo Pharma, Inc. (SILO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
315.84K
5-year avg
6.22M
10-year avg
11.42M
Silo Pharma, Inc.’s Enterprise Value is less than Protagenic Therapeutics, Inc. (1.79M), less than Rezolute, Inc. (235.52M), less than Lumos Pharma, Inc. (25.64M), less than Anebulo Pharmaceuticals, Inc. (45.92M), less than Sino Biopharmaceutical Limited (11.80B), less than Inventiva S.A. (230.21M), less than BioCardia, Inc. (7.95M), less than UroGen Pharma Ltd. (381.29M), less than Indaptus Therapeutics, Inc. (4.86M), less than Tempest Therapeutics, Inc. (14.12M), greater than Comera Life Sciences Holdings, Inc. (-1593200.00), greater than Forte Biosciences, Inc. (-3085005.00), less than Pardes Biosciences, Inc. (34.92M), greater than Shattuck Labs, Inc. (-1271695.00), less than Eliem Therapeutics, Inc. (119.64M), less than Champions Oncology, Inc. (61.85M), less than Century Therapeutics, Inc. (122.08M), less than Acumen Pharmaceuticals, Inc. (137.49M), greater than HOOKIPA Pharma Inc. (-26987206.00), less than Day One Biopharmaceuticals, Inc. (1.08B), less than Inozyme Pharma, Inc. (308.45M), less than Terns Pharmaceuticals, Inc. (504.87M),
Company | Enterprise Value | Market cap |
---|---|---|
1.79M | $2.85M | |
235.52M | $303.69M | |
25.64M | $35.99M | |
45.92M | $49.01M | |
11.80B | $8.67B | |
230.21M | $238.98M | |
7.95M | $8.23M | |
381.29M | $503.05M | |
4.86M | $12.03M | |
14.12M | $24.99M | |
-1593200.00 | $3.07K | |
-3085005.00 | $6.49M | |
34.92M | $135.19M | |
-1271695.00 | $55.60M | |
119.64M | $342.68M | |
61.85M | $57.64M | |
122.08M | $107.17M | |
137.49M | $177.24M | |
-26987206.00 | $45.26M | |
1.08B | $1.50B | |
308.45M | $276.97M | |
504.87M | $596.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silo Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Silo Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Silo Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Silo Pharma, Inc. (SILO)?
What is the 3-year average Enterprise Value for Silo Pharma, Inc. (SILO)?
What is the 5-year average Enterprise Value for Silo Pharma, Inc. (SILO)?
How does the current Enterprise Value for Silo Pharma, Inc. (SILO) compare to its historical average?